Market Overview:
The global GMP grade cytokines market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for GMP grade cytokines for cell and gene therapy, tissue-engineered products, and other applications. North America is expected to dominate the global GMP grade cytokines market during the forecast period, followed by Europe and Asia Pacific. The growth in these regions can be attributed to the increasing demand for GMP grade cytokines for cell and gene therapy applications.
Product Definition:
GMP grade cytokines are highly purified and consistent cytokines that have been manufactured in accordance with good manufacturing practices (GMP). GMP grade cytokines are important for research and therapeutic applications, as they provide a reliable source of these proteins that can be used with confidence.
TNF:
TNF, it's usage and growth factor in GMP grade Cytokines market is expected to grow at a significant rate over the forecast period. The global TNF, it's usage and growth factor in GMP grade cytokinins market size was valued at USD 6.5 million in 2015 and is projected to grow with CAGR of XX% over the forecast period.
Interleukin:
Interleukin (IL) is a cytokine that belongs to the family of interferons. Interleukins are type of protein cell signaling molecules produced by cells in response to viral infections, immunological threats, and other stress factors. ILs are mainly produced by activated T-cell lymphocytes but also can be produced by other immune cells such as Natural killer (NK) cells, macrophages and dendritic cells.
Application Insights:
Cell/gene therapy, tissue-engineered products, and other applications are the major application segments of the global GMP grade cytokines market. Cell/gene therapy is estimated to be the fastest-growing segment over the forecast period owing to increasing R&D activities for developing cell therapies for various diseases.
The others segment includes vaccine development and production as well as product evaluation & testing purposes. The growth of this application segment can be attributed to extensive R&D initiatives undertaken by several companies in order to develop novel products with enhanced efficacy and safety profiles. For instance, cytokine cocktails are being used in combination therapies that target multiple symptoms simultaneously without causing severe side effects compared with monotherapy use of these drugs (Sanchez et al., 2016). This trend is expected to drive market growth during future years.
Regional Analysis:
North America dominated the global market in 2017. The presence of major players, favorable reimbursement policies, and increasing investments for R&D are some of the factors responsible for its large share. In addition, North America is a mature region when compared to Asia Pacific and Latin America.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to various factors such as growing economy & population coupled with rising healthcare expenditure along with government support for quality medicines & biologics production in emerging countries such as China & India will drive this regional market at an exponential CAGR during the forecast period.
In addition, supportive government initiatives encouraging domestic level private investment (LLP) are anticipated to fuel growth over next eight years across all economies globally including Middle East Africa (MEA).
Growth Factors:
- Increasing demand for GMP grade cytokines owing to their therapeutic potential in various diseases such as cancer, autoimmune disorders, and infectious diseases.
- Rising prevalence of chronic diseases that require regular administration of cytokines for treatment is expected to boost the market growth.
- Growing number of clinical trials being conducted for development of novel therapeutics using GMP grade cytokines is anticipated to propel the market growth over the forecast period.
- Technological advancements in manufacturing process and increasing R&D investments by key players are likely to provide impetus to the market growth during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
GMP Grade Cytokines Market Research Report
By Type
TNF, Interleukin, Growth Factor, Others
By Application
Cell/Gene Therapy, Tissue-Engineered Products, Others
By Companies
Miltenyi Biotec, Bio-Techne, GE Healthcare, Lonza, CellGenix, ReproCELL, PeproTech, Sino Biological, Creative Bioarray, Akron Biotech, Almog
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global GMP Grade Cytokines Market Report Segments:
The global GMP Grade Cytokines market is segmented on the basis of:
Types
TNF, Interleukin, Growth Factor, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cell/Gene Therapy, Tissue-Engineered Products, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Miltenyi Biotec
- Bio-Techne
- GE Healthcare
- Lonza
- CellGenix
- ReproCELL
- PeproTech
- Sino Biological
- Creative Bioarray
- Akron Biotech
- Almog
Highlights of The GMP Grade Cytokines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- TNF
- Interleukin
- Growth Factor
- Others
- By Application:
- Cell/Gene Therapy
- Tissue-Engineered Products
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the GMP Grade Cytokines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
GMP grade cytokines are those that have been specifically tested and found to be free of any contaminants that could potentially cause adverse effects.
Some of the major companies in the gmp grade cytokines market are Miltenyi Biotec, Bio-Techne, GE Healthcare, Lonza, CellGenix, ReproCELL, PeproTech, Sino Biological, Creative Bioarray, Akron Biotech, Almog.
The gmp grade cytokines market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 GMP Grade Cytokines Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 GMP Grade Cytokines Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 GMP Grade Cytokines Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the GMP Grade Cytokines Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global GMP Grade Cytokines Market Size & Forecast, 2018-2028
4.5.1 GMP Grade Cytokines Market Size and Y-o-Y Growth
4.5.2 GMP Grade Cytokines Market Absolute $ Opportunity
Chapter 5 Global GMP Grade Cytokines Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 GMP Grade Cytokines Market Size Forecast by Type
5.2.1 TNF
5.2.2 Interleukin
5.2.3 Growth Factor
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global GMP Grade Cytokines Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 GMP Grade Cytokines Market Size Forecast by Applications
6.2.1 Cell/Gene Therapy
6.2.2 Tissue-Engineered Products
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global GMP Grade Cytokines Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 GMP Grade Cytokines Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America GMP Grade Cytokines Analysis and Forecast
9.1 Introduction
9.2 North America GMP Grade Cytokines Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America GMP Grade Cytokines Market Size Forecast by Type
9.6.1 TNF
9.6.2 Interleukin
9.6.3 Growth Factor
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America GMP Grade Cytokines Market Size Forecast by Applications
9.10.1 Cell/Gene Therapy
9.10.2 Tissue-Engineered Products
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe GMP Grade Cytokines Analysis and Forecast
10.1 Introduction
10.2 Europe GMP Grade Cytokines Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe GMP Grade Cytokines Market Size Forecast by Type
10.6.1 TNF
10.6.2 Interleukin
10.6.3 Growth Factor
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe GMP Grade Cytokines Market Size Forecast by Applications
10.10.1 Cell/Gene Therapy
10.10.2 Tissue-Engineered Products
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific GMP Grade Cytokines Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific GMP Grade Cytokines Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific GMP Grade Cytokines Market Size Forecast by Type
11.6.1 TNF
11.6.2 Interleukin
11.6.3 Growth Factor
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific GMP Grade Cytokines Market Size Forecast by Applications
11.10.1 Cell/Gene Therapy
11.10.2 Tissue-Engineered Products
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America GMP Grade Cytokines Analysis and Forecast
12.1 Introduction
12.2 Latin America GMP Grade Cytokines Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America GMP Grade Cytokines Market Size Forecast by Type
12.6.1 TNF
12.6.2 Interleukin
12.6.3 Growth Factor
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America GMP Grade Cytokines Market Size Forecast by Applications
12.10.1 Cell/Gene Therapy
12.10.2 Tissue-Engineered Products
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) GMP Grade Cytokines Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) GMP Grade Cytokines Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) GMP Grade Cytokines Market Size Forecast by Type
13.6.1 TNF
13.6.2 Interleukin
13.6.3 Growth Factor
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) GMP Grade Cytokines Market Size Forecast by Applications
13.10.1 Cell/Gene Therapy
13.10.2 Tissue-Engineered Products
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 GMP Grade Cytokines Market: Competitive Dashboard
14.2 Global GMP Grade Cytokines Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Miltenyi Biotec
14.3.2 Bio-Techne
14.3.3 GE Healthcare
14.3.4 Lonza
14.3.5 CellGenix
14.3.6 ReproCELL
14.3.7 PeproTech
14.3.8 Sino Biological
14.3.9 Creative Bioarray
14.3.10 Akron Biotech
14.3.11 Almog
